KOREAN
Company
Business
R & D
Investors
Company Overview
Welcome Message
Vision & Mission
History
C.I
Careers
Contact Us
Umbilical Cord Blood-derived Stem Cell
Stem Cell Therapy
Stem Cell Conditioned Media
Stem Cell Culture Media
Cell Freezing and Thawing Platform
CDMO
Health & Beauty(H&B) Business
Core Technology
Global R&D Center
Stem Cell GMP Center
Pipeline
Notice
IR
PR
Investors
Notice
IR
Disclosure Information
Stock Information
IR Resource Center
IR Letter & FAQ
PR
Press Release
PR Resource Center
IR Letter & FAQ
Investors
IR
IR Letter & FAQ
[IR FAQ] 2022년 1분기 FAQ리포트_"최근 구체적으로 논의되고 있는 License Out (L/O) 건이 있습니까?"
2022/06/02 09:34:04
FAQ3.jpg
(104.65 KB)
목록으로
[IR FAQ] 골관절염치료제 (FURESTEM-OA Kit주) 1/2a 상 임상시험계획(IND) 자진취하 공시의 배경은 무엇입니까?
[IR FAQ] 2022년 1분기 FAQ리포트_"코로나팬데믹 등 여러 요인이 있는데 아토피 피부염 치료제 (Furestem-AD 주)관련 임상모집은 문제없이 진행되고 있습니까?"
About Us
Stock Information
Careers
Contact Us
Global R&D Center
Stem Cell GMP Center
Pipeline
TOP
pr : ir_faq : view : : /pr/ir_faq/view